| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/28/2009 | CA2706467A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 05/27/2009 | EP2062977A1 Fucosyltransferase-gen |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062887A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP2062597A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2061782A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/27/2009 | EP2061497A1 Compositions and methods for treatment of chronic fatigue syndrome and neurodegenerative diseases |
| 05/27/2009 | EP2061484A2 Treatment, prevention, and reversal of alcohol-induced liver disease |
| 05/27/2009 | EP2061442A2 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 05/27/2009 | EP1878431A4 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1408045B1 Novel galactosylceramide analogs and beta-glucocerebrosidase activators,external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | EP1244448B1 Novel methods for the treatment and prevention of ileus |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | EP1003850B1 Inhibitors of dna immunostimulatory sequence activity |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | EP0871487B1 Dendritic cell stimulatory factor |
| 05/27/2009 | CN101443344A Trehalose compound and pharmaceutical comprising the compound |
| 05/27/2009 | CN101443014A Chemical compounds |
| 05/27/2009 | CN101443010A Brain function-improving agent, and functional food containing the improving agent |
| 05/27/2009 | CN101443004A Formulations and methods for vascular permeability-related diseases or conditions |
| 05/27/2009 | CN101442993A Adhesive preparation |
| 05/27/2009 | CN101439181A Stable water injection medicament composition containing Ulinastatin |
| 05/27/2009 | CN101439092A Navel paste for treating diarrhea, enuresis, night sweat and spontaneous perspiration, and preparation method thereof |
| 05/27/2009 | CN100491396C Selective cyclic peptides |
| 05/27/2009 | CN100491392C Blanched polyamine steroid derivatives |
| 05/27/2009 | CN100491389C Sialic combined immunoglobulin like agglutinin inhibitors |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491372C Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100491360C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491352C Asymmetrical cyclic diamine compound |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491336C Novel derivatives of 3,3-diphenylpropylamines |
| 05/27/2009 | CN100490896C Chewing tablet for discharging lead, and preparation method |
| 05/27/2009 | CN100490845C Herbal composition and its use in chemotheraphy |
| 05/27/2009 | CN100490826C Method for preparing concatenated active bifidobacterium product |
| 05/27/2009 | CN100490817C Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/27/2009 | CN100490797C Pharmaceutical compositions |
| 05/27/2009 | CN100490791C Compositions and methods to treat neovascularization and disease associated with thereof |
| 05/27/2009 | CN100490781C Pharmaceutical composition for treating qi and blood deficiency and its preparation method |
| 05/26/2009 | US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression |
| 05/26/2009 | US7538220 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | US7538093 Compositions and methods for therapeutic use |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537924 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 05/26/2009 | US7537908 Using concentration of high mobility group 1 (HMG1) protein as evaluative tool in detection of infection and acute respiratory distress syndrome; treating obesity with high mobility group antagonist |
| 05/26/2009 | US7537906 inhibition of Akt activity or inhibition of the survival signalling pathway in which Akt is involved in the cells, akt is a kinase |
| 05/26/2009 | US7537759 Modulating angiogenesis |
| 05/26/2009 | US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 05/26/2009 | US7537752 Mixture of chelate compound and active material in vehicle |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2441441C Combination of a taxane and a cyclin-dependent kinase inhibitor |
| 05/26/2009 | CA2439671C Aquatic animal treatment method and composition containing pimenta extract |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2403630C Methods for inhibiting angiogenesis and tumor growth |
| 05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2355077C Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 05/26/2009 | CA2354774C Farnesyl protein transferase inhibitors |
| 05/26/2009 | CA2339495C Phospholipids with unsaturated alkyl and acyl chains |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009064195A2 Reduced sexual maturation in fish |
| 05/22/2009 | WO2009063998A1 Nucleic acid having hydrophobic substance added thereto, and use thereof |
| 05/22/2009 | WO2009063995A1 Diagnosis and treatment of arteriosclerosis |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063992A1 Condensed pyridine derivative and use thereof |
| 05/22/2009 | WO2009063991A1 Pyridooxazepine derivative and use thereof |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063885A1 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) |
| 05/22/2009 | WO2009063872A1 Pseudoginseng extract |
| 05/22/2009 | WO2009063821A1 Heteroaryloxy quinazoline derivative |
| 05/22/2009 | WO2009062910A1 Composition for moderating triglyceride and cholesterol levels |
| 05/22/2009 | WO2009032308A3 Sam-ii riboswitch and uses thereof |
| 05/22/2009 | WO2009025820A3 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 05/22/2009 | WO2008073851A3 Remotely triggered release from heatable surfaces |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |